Etiometry Joins Partners Cooperative, Inc. to Streamline the Enablement of AI-based Clinical Intelligence for High-acuity Care Teams in Member Hospitals

Partnership aims to improve outcomes for intensive care patients and deliver savings in the costliest units of the hospital through use of Etiometry’s clinical decision support platform BOSTON, Mass. – Oct. 5, 2023 – Etiometry, the leader in clinical decision support software for critical care, announced a partnership agreement with Partners Cooperative, Inc,  an organization formed…

Etiometry Joins Forces with SRHO to Enable AI-based Decision Support in High-acuity Hospital Units across the U.S.

Partnership aims to improve outcomes and drive cost efficiencies within critical care units of SRHO – The National Organization member hospitals through the use of Etiometry’s clinically-proven decision support platform  BOSTON, Mass. – Sept. 28, 2023 – Etiometry, a leader in clinical intelligence technology for critical care entered a strategic partnership with SRHO – The National…

Outcomes Data Reveal Significant Impact of Etiometry Utilization in Liberating Patients from Invasive ICU Treatments

Studies presented at World Congress of Pediatric Cardiology and Cardiac Surgery show Etiometry’s clinical intelligence platform supports efficient escalation and safe de-escalation decisions to enhance patient outcomes and reduce length of stay   BOSTON, Mass. – Aug. 28, 2023 – Etiometry, the leader in clinical decision-support software, shares exciting new study results from ten hospitals, including…

Etiometry Bolsters Data Security by Achieving SOC 2 Compliance

SOC 2 attestation underscores Etiometry’s commitment to robust data protection mechanisms for its hospital customers pursuing cloud technologies BOSTON, Mass. – Aug 15, 2023 – Etiometry, the leader in clinical decision-support software for high-acuity care teams, has successfully completed its Systems and Organizational Control (SOC) 2 Type 2 examination. As one of the most stringent, industry-accepted…

Etiometry Gains FDA Clearance of AI-Based Algorithm that Alerts Risk of Hypercapnia for Neonates in Critical Care

Etiometry’s IVCO2 Index™ is now available for continuous non-invasive NICU ventilation monitoring for optimal outcomes without additional devices   BOSTON, Mass. – Aug. 1, 2023 – Etiometry, the leader in clinical decision-support software, announced today its IVCO2 Index™ was cleared by the Food and Drug Administration for use with neonatal ICU patients under 2kg, who are…

Etiometry Announces CE Mark and Health Canada Authorization for Adult Use of AI-Based Algorithm that Detects Risk of Hypercapnia

Previously authorized for pediatric populations, critical care teams in Europe and Canada can now utilize Etiometry’s IVCO2 IndexTM to determine the likelihood of inadequate carbon dioxide ventilation in adults BOSTON, Mass. – March 21, 2023 – Etiometry, the leader in clinical decision-support software for critical care, today announced CE Mark and Health Canada authorization of…

Etiometry is the First to Achieve FDA Clearance of an AI-Based Risk Algorithm that Alerts for Inadequate Oxygenation of Adult Patients in Critical Care

U.S. Hospitals can now equip clinicians in adult ICUs with Etiometry’s IDO2 Index™ to rapidly identify changes to patients’ condition. BOSTON, Mass. – January 24, 2023 – Etiometry, a leader in clinical decision-support software, announced today its IDO2 Index™ was cleared for adult use by the Food and Drug Administration. Now, U.S. hospitals can arm…

Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution

The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, TX. – November 29th, 2022 – Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with…

Etiometry’s Clinical Decision-Support Software Receives CE Mark

This marks the latest regulatory approval for Etiometry as the second adult and third pediatric market authorization October 12, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union’s medical device regulation, marking the…